Amgen to invest $1 billion in North Carolina manufacturing site

(Reuters) – U.S. drugmaker Amgen said on Thursday it will invest $1 billion towards a second drug substance manufacturing facility in North Carolina.

(Reporting by Bhanvi Satija in Bengaluru; Editing by Tasim Zahid)